Takeda Pharmaceutical (TAK) Enterprise Value (2018 - 2026)
Takeda Pharmaceutical's Enterprise Value came in at -$3.47 billion for the quarter ended Jun 30, 2026, compared with -$2.51 billion a year earlier.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Enterprise Value (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Takeda Pharmaceutical reported Enterprise Value of -$24.19 billion; for the year ended Mar 31, 2026, it was -$4.19 billion.
- Going back by year, Enterprise Value was -$2.68 billion in the year ended Mar 31, 2025, -$4.06 billion in the year ended Mar 31, 2024, -$5.99 billion in the year ended Mar 31, 2023 and -$8.62 billion in the year ended Mar 31, 2022.
- The five-year range for quarterly Enterprise Value is -$7.26 billion (the quarter ended Mar 31, 2022) to -$1.72 billion (the quarter ended Dec 31, 2023).
- Business Quant data shows TAK's Enterprise Value at -$3.91 billion (quarter ended Mar 31, 2026), -$4.75 billion (quarter ended Dec 31, 2025) and -$4.98 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.47 Bn |
| Mar 31, 2026 | -3.91 Bn |
| Dec 31, 2025 | -4.75 Bn |
| Sep 30, 2025 | -4.98 Bn |
| Jun 30, 2025 | -2.51 Bn |
| Mar 31, 2025 | -2.67 Bn |
| Dec 31, 2024 | -3.95 Bn |
| Sep 30, 2024 | -5.47 Bn |
| Jun 30, 2024 | -5.61 Bn |
| Mar 31, 2024 | -3.39 Bn |
| Dec 31, 2023 | -1.72 Bn |
| Sep 30, 2023 | -3.63 Bn |
| Jun 30, 2023 | -2.18 Bn |
| Mar 31, 2023 | -3.77 Bn |
| Dec 31, 2022 | -5.71 Bn |
| Sep 30, 2022 | -6.66 Bn |
| Jun 30, 2022 | -6.75 Bn |
| Mar 31, 2022 | -7.26 Bn |
| Jun 30, 2021 | -5.93 Bn |
| Mar 31, 2021 | -8.70 Bn |
API Access
Takeda Pharmaceutical Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();